Marketing applications for abiraterone in the U.S. and Europe are scheduled to be filed by the end of this year.
Dhanka kale, codsiyada isdiiwaangelinta naqshada gaadhiga TOGG ee Asia iyo America oo imika la hakiyey ayaa la filayaa in la dhammeeyo sannadkan.